Background: Ultraviolet (UV) goes through the epidermis and promotes release of inflammatory cytokines in keratinocytes. Granulocyteemacrophage colony-stimulating factor (GM-CSF), one of the keratinocyte-derived cytokines, regulates proliferation and differentiation of melanocytes. Extracellular signaleregulated kinase (ERK1/2) and protein kinase C (PKC) signaling pathways regulate expression of GM-CSF. Based on these results, we found that ginsenoside Rh3 prevented GM-CSF production and release in UV-Beexposed SP-1 keratinocytes and that this inhibitory effect resulted from the reduction of PKCd and ERK phosphorylation. Methods: We investigated the mechanism by which ginsenoside Rh3 from Panax ginseng inhibited GM-CSF release from UV-Beirradiated keratinocytes. Results: Treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) or UV-B induced release of GM-CSF in the SP-1 keratinocytes. To elucidate whether the change in GM-CSF expression could be related to PKC signaling, the cells were pretreated with H7, an inhibitor of PKC, and irradiated with UV-B. GM-CSF was decreased by H7 in a dose-dependent manner. When we analyzed which ginsenosides repressed GM-CSF expression among 15 ginsenosides, ginsenoside Rh3 showed the largest decline to 40% of GM-CSF expression in enzyme-linked immunosorbent assay. Western blot analysis showed that TPA enhanced the phosphorylation of PKCd and ERK in the keratinocytes. When we examined the effect of ginsenoside Rh3, we identified that ginsenoside Rh3 inhibited the TPA-induced phosphorylation levels of PKCd and ERK. Conclusion: In summary, we found that ginsenoside Rh3 impeded UV-Beinduced GM-CSF production through repression of PKCd and ERK phosphorylation in SP-1 keratinocytes.
Introduction
The skin is the organ that covers all of the body and is mainly composed of the epidermis and dermis. The epidermis consists of keratinocytes (approximately 90%) and melanocytes (5e10%) [1] . Melanocytes originate from neural crest cells and synthesize melanin pigments [2] . Skin pigmentation plays many beneficial roles that include determination of skin color of humans and ultraviolet (UV) radiation protection [3] . Excessive exposure to UV-B (280e320nm) accelerates skin aging such as wrinkle formation and hyperpigmentation [1] . Production of proinflammatory cytokines and growth factors mediates skin damage [4] . There is evidence showing that granulocyteemacrophage colony-stimulating factor (GM-CSF) is an important cytokine in the control of the proliferation and differentiation of melanocytes in pigmented spots induced by UV [5] . Previous studies have shown that protein kinase C (PKC) and the following activation of the extracellular signaleregulated kinase (ERK) pathway regulate GM-CSF expression [6] .
PKC is composed of a large family of 11 members of kinases, which are categorized into conventional (cPKCs; a, bI, bII, g), novel (nPKCs; d, e, h, q, m), and atypical (aPKCs; s, z) protein kinases [7, 8] .
The cPKCs and nPKCs can be stimulated using phorbol esters and diacylglycerol; on the other hand, the aPKCs have been reported to show no response to phorbol esters and diacylglycerol either in vivo or in vitro [9] . It has been reported that UV-B markedly induces the activation of PKCd and PKCε but has no effect on PKCa [10, 11] . The Korean Red Ginseng (KRG) saponin has been known to exert anticancer, antiaging, antioxidant, and antiinflammatory effects, with a low rate of adverse effects [12, 13] .
Previous studies have shown that UV-B irradiation stimulated production of GM-CSF in SP-1 keratinocytes and that this induction of GM-CSF promoted mouse melanocyte proliferation. In addition, KRG saponin inhibited secretion of GM-CSF from mouse keratinocytes induced by UV-B [12] .
Saponin consists of various ginsenosides that are divided into two major groups, the panaxadiols and panaxatriols, based on the chemical structure [13] . Ginsenosides are the main compounds responsible for most of the pharmacological and immunological effects of saponin [14] . However, the inhibitory mechanisms of ginsenoside activity on UV-induced skin pigmentation still remain unclear. In this research, we investigated the inhibitory mechanism of ginsenoside Rh3 in cellular protection against expression and release of GM-CSF induced by UV-B in SP-1 keratinocytes.
Materials and methods

Cell line and cell culture
SP-1 keratinocytes from Sencar mice were kindly gifted from Dr. Stuart H. Yuspa (Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, NIH, USA). Eagle's minimum essential medium (EMEM) complemented with 8% Chelex-treated heat-inactivated newborn calf serum (Carlsbad, CA, USA), 1% penicillinestreptomycin, and 0.05 mM Ca 2þ was used for the in vitro culture of the SP-1 keratinocytes.
Materials
Ginsenosides compound K, F1, F2, Rb1, Rb2, Rb3, Rc, Rd, Re, Rh1, Rh3, Rg1, Rg2, Rf, and Ro were provided by Korea Ginseng Corporation (Daejeon, Korea).
Irradiation
For irradiation, the medium was changed to Dulbecco's phosphate-buffered saline, and the keratinocytes were treated with UV-B (30 mJ/cm 2 ). The cells were then maintained in EMEM containing 2% newborn calf serum for the indicated times.
Cell viability assay
The SP-1 keratinocytes were cultured and placed in 96-well plates (1.0 Â 10 4 cells/well). After 24 h, the cells were treated with ginsenoside Rh3 (1, 10, 100, and 1000 mM) and incubated for 24 h. Then, cell viabilities were determined using an EZ-Cytox assay kit (Daeil Lab Service, Seoul, Korea).
Reverse transcription polymerase chain reaction analysis
TRIzol reagent (Takara Bio, Inc., Tokyo, Japan) was used to extract total RNAs from the SP-1 keratinocytes. Complementary DNAs were amplified by reverse transcription polymerase chain reaction (RT-PCR) using the following primers: GM-CSF, forward: These experiments were performed in triplicate. DMSO, dimethyl sulfoxide. Fig. 3 . Ginsenoside Rh3 reduced TPA-induced GM-CSF production. SP-1 cells were treated with 50 nM TPA after 24 h of treatment with ginsenoside Rh3. Six hours later, the conditioned medium was collected to measure the concentration of GM-CSF. Expression of GM-CSF was detected by ELISA.
### p < 0.001 compared with dimethyl sulfoxide (D,
"DMSO") 0.1% control, *p < 0.05, **p < 0.01 compared with the TPA-treated group, n ¼ 3. ELISA, enzyme-linked immunosorbent assay; GM-CSF, granulocyteemacrophage colony-stimulating factor; TPA, 12-O-tetradecanoylphorbol-13-acetate.
Western blot analysis
Total extracts were prepared with radioimmunoprecipitation assay buffer (RIPA buffer) (Noble Bio, Hwaseong, Korea) containing 1 mM phenylmethanesulfonyl fluoride and protease inhibitor cocktail (cat#P8340; Sigma, St. Louis, MO, USA). The proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using NuPAGE 10% BiseTris gels and transferred to a polyvinylidene fluoride transfer membrane (Pall Corporation, Port Washington, NY, USA) using NuPAGE 3-(N-morpholino) propane sulphonic acid (MOPS) SDS running buffer (cat# NP0001; Invitrogen) and NuPAGE transfer buffer 20Â (cat# NP0006; InvitrogenÔ).
Western blot was performed using antibodies against antieGM-CSF antibody ( 
Measurement of GM-CSF by enzyme-linked immunosorbent assay
Culture supernatants were collected 24 h after UV-B irradiation. The medium was centrifuged at 1000 rpm for 5 min and stored at À80 C. The GM-CSF in the culture supernatants was determined using a mouse GM-CSF enzyme-linked immunosorbent assay kit (eBioscience, San Diego, CA, USA) as per the manufacturer's instructions.
Statistical analysis
All values are expressed as mean AE standard error of mean. Significant differences between the results were evaluated using the Student t test. The p-values < 0.05 were regarded as statistically significant.
Results
Ginsenoside Rh3 inhibited production of GM-CSF in the UV-Be exposed SP-1 keratinocytes
We identified 15 types of ginsenosides to determine which ginsenoside reduced GM-CSF expression in SP-1 keratinocytes. Enzyme-linked immunosorbent assaywas used to quantify the GM-CSF levels from the SP-1 keratinocyteecultured media. GM-CSF was increased in the culture media after UV-B exposure compared with the nonirradiated control cell media. Among the compounds tested, ginsenoside Rh3 resulted in an approximate 40% decrease in the GM-CSF level. Based on these results, we selected ginsenoside Rh3 for further study (Fig. 1). 
Effect of ginsenoside Rh3 on cell viability
The cytotoxic effect of ginsenoside Rh3 was investigated on the SP-1 keratinocytes. We found that ginsenoside Rh3 did not affect cell viability at concentrations of 1e1000 mM (Fig. 2) .
Ginsenoside Rh3 reduced 12-O-tetradecanoylphorbol-13-acetateeinduced GM-CSF production
We investigated whether ginsenoside Rh3 could inhibit 12-Otetradecanoylphorbol-13-acetate (TPA)einduced GM-CSF production in SP-1 cells. H7 (PKC inhibitor) was used as a positive control for the reduction in GM-CSF induced by TPA. We found that ginsenoside Rh3 reduced production of GM-CSF induced by 50 nM TPA in a dose-dependent manner (Fig. 3) .
Ginsenoside Rh3 reduced TPA-induced GM-CSF mRNA expression
The SP-1 cells were treated with 50 nM TPA and ginsenoside Rh3 for 0, 3, and 6 h. To detect the GM-CSF mRNA level, we used RT-PCR. We observed that GM-CSF mRNA levels significantly increased at 3 and 6 h after TPA treatment and that ginsenoside Rh3 and H7 decreased the GM-CSF mRNA level in the TPA-treated SP-1 cells at 6 h (Fig. 4) .
Differential activity of PKC isoforms in the UV-B radiatione induced SP-1 keratinocytes
We then examined which PKC isoforms are activated by UV-B radiation. By Western blot analysis, we confirmed that the PKCd isoform was activated 5 min after UV-B exposure. However, the PKCa isoform was not activated after UV-B irradiation (Fig. 5) . These results demonstrated that PKCd is involved in UV-Beinduced GM-CSF expression.
Effect of ginsenoside Rh3 on phosphorylation of PKCd induced by TPA in the SP-1 keratinocytes
We identified whether ginsenoside Rh3 could suppress the TPAinduced phosphorylation of PKCd and ERK. We observed that the phosphorylation levels of PKCd and ERK increased rapidly after 3 min of 100 nM TPA treatment and that ginsenoside Rh3 reduced the phosphorylation (Fig. 6A) . The results of the Western blot analysis of phospho-PKCd and phospho-ERK were quantified using an image analyzer ( Fig. 6B and C) .
Discussion
Exposure to continuous and excessive UV-B radiation is a major cause of skin damage including sunburn, skin aging, erythema, and skin cancer [15] . UV irradiation promotes the secretion of various inflammatory cytokines and chemokines from keratinocytes [4, 16] . It is known that GM-CSF is produced by UV irradiation in keratinocytes and increases skin pigmentation by controlling the proliferation and differentiation of melanocytes [17] . In our previous study, treatment with KRG saponin and ginsenoside Rh3 decreased GM-CSF release and expression in UV radiationeexposed keratinocytes [18] . Saponin consists of various ginsenosides, which have numerous functions [12] . We tested 15 types of ginsenosides to identify which ginsenosides repress GM-CSF expression. We found that ginsenoside Rh3 inhibited GM-CSF production in UV-Be exposed SP-1 keratinocytes (Fig. 1) . Ginsenoside Rh3 is a metabolite of ginsenoside Rg5 in humans [19] . Pharmacological studies found that ginsenoside Rg5 and Rh3 have anticancer and antiinflammatory activities [19, 20] . In addition, Rh3 was reported to inhibit lipopolysaccharides (LPS-)induced cytokines such as inducible nitric oxide synthase, tumor necrosis factor-a, and interleukin-1b (IL-1b) [21] . In our study, ginsenoside Rh3 suppressed TPA-induced GM-CSF protein expression (Fig. 3) and reduced GM-CSF mRNA level in the TPA-treated SP-1 cells (Fig. 4) . The cPKC and nPKC can be directly activated by TPA and inhibited by H7 [22, 23] . It has been reported that PKC signaling is activated in response to UV irradiation [24] . However, the PKC isoforms have different functions and reactions. UV irradiation activates phosphorylation of PKCd, but not PKCa [25] . We investigated whether phosphorylation of PKC isoforms is activated by UV-B irradiation in SP-1 cells. After UV-B irradiation (30 mJ/cm 2 ), PKCd was phosphorylated after 5 min, and this phosphorylation was maintained for 1 hr. However, PKCa was not phosphorylated by UV-B irradiation (Fig. 5 ). These results demonstrate that PKCd is involved in UVBeinduced GM-CSF production. The PKC-ERK pathway regulates proliferation and differentiation and is an antiapoptotic pathway in keratinocytes [26] . It has been reported that PKC activates MAPK/ ERK Kinase (MEK)-ERK pathway [27] . Furthermore, phosphorylation of ERK contributes to the generation of GM-CSF through the translation and stabilization of GM-CSF [28] . Similar to UV-B irradiation, treatment of cells with TPA increased phosphorylation of ERK and PKCd. We found that ginsenoside Rh3 inhibited TPAinduced phosphorylation of PKCd and ERK (Fig. 6 ). Taken together, we identified that UV-B increased GM-CSF expression through PKCd activation. Our results showed the inhibitory effect of ginsenoside Rh3 on UV-Beinduced GM-CSF expression and the inhibitory mechanism of GM-CSF through the repression of PKCd phosphorylation in SP-1 cells. Thus, our finding shows that ginsenoside Rh3 can suppress UV-Beinduced PKCd activation. GM-CSF is also induced by UV light and has autocrine or paracrine function in human skin [29, 30] . It is therefore possible that ginsenoside Rh3 has an effect on the production of GM-CSF in cultured human keratinocytes. PKCd has been known to implicate in various cellular processes such as apoptosis, migration, and differentiation [9, 31, 32] . In addition, PKCd plays an important role in regulation of inflammatory cytokines, including IL-6, IL-8, and interferon-g. Immunohistochemistry and PCR analysis showed decreased expression of IL-6 and monocyte chemoattractant protein-1 in the aortic tissues of PKCd knockout mice [33, 34] . Despite the fact that PKCd is involved in diverse biological activities such as glucose metabolism, neuropathogenesis, and tonic tension, few PKCd inhibitors have been reported [35e38] . Recently, we found that ginsenoside Rh3 decreased the proliferation of mouse melanocytes through downregulation of microphthalmia-associated transcription factor, a key regulator of melanocytes [39] . In this regard, we suggest that ginsenoside Rh3 may be a bioactive compound targeting PKCd and a potential agent to suppress UV-Beinduced skin pigmentation.
An earlier report has shown that ginsenoside Re has a protective role in methamphetamine-induced apoptosis via PKCd inhibition in SH-SY5Y neuroblastoma cells [40] . In contrast, other groups suggested that ginsenoside Rh2 induced PKCd activity and apoptosis in SK-HEP-1 hepatoma cells [41] . Our findings that ginsenoside Rh3 may be a potential PKCd inhibitor can be applied to the aforementioned studies. Further studies on the effect of ginsenoside Rh3 on reactive oxygen species produced by UV-B, based on the reported result that the PKCs are regulated by UV-induced reactive oxygen species, will need to be performed [42, 43] .
Conflicts of interest
The authors declare that there are no conflicts of interest.
